Crimped on an Oceanus 35, offering short deflation times and great pushability and trackability.
Great profiles
6F compatible for all diameters.
Unique stent design
Provides superior conformability to the vessel wall.
Low restenosis
Advance manufacturing process to minimise the potential restenosis.
Q six, the certified quality of all iVascular stents
No random picking ensuring an automatized analysis of 100% stents.
Assures the perfect surface finishing.
Accurate dimensional analysis of the stent struts.
3D control, struts 100% checked.
High radial force with mínimum recoil to be able to treat BTK lesions.
Specifically designed for homogeneous arterial coverage.
Coating technology
TransferWise, the iVascular proprietary technology that provides a homogenous drug elution that translates into lower rates of restenosis and inflammation score.
Our fluoro-acrylate polymer provides an early endothelialization and creates a thromboresistant layer.
CLINICAL SUPPORT
Angiolite BTK has demonstrated its safety and efficacy in the following clinical trial:
ANGIOLITE BTK Trial
Prospective, real-life trial in BTK lesions.
88% PP
at 6 months.